07 July 2024 Amplia Therapeutics: COMPLETION OF RECRUITMENT OF FIRST 26 PATIENTS IN PHASE 2A ACCENT TRIAL 0 minute read Pharma/Biotech By Cate Swannell Previous Post Next Post